Merck Q3 KEYTRUDA/KEYTRUDA QLEX Sales $8.60B (+6% Y/Y)
Benzinga Newsdesk 4 days ago
EarningsNews
Total Worldwide Sales Were $18.1 Billion (5% Growth; 4% Growth ex-FX)KEYTRUDA/KEYTRUDA QLEX1 Sales Were $8.6 Billion (6% Growth; 6% Growth ex-FX); Includes KEYTRUDA QLEX Sales of $830 MillionWINREVAIR Sales Were $694
Total Worldwide Sales Were $18.1 Billion (5% Growth; 4% Growth ex-FX)
- KEYTRUDA/KEYTRUDA QLEX1 Sales Were $8.6 Billion (6% Growth; 6% Growth ex-FX); Includes KEYTRUDA QLEX Sales of $830 Million
- WINREVAIR Sales Were $694 Million (93% Growth; 94% Growth ex-FX)
- Animal Health Sales Were $1.7 Billion (4% Growth; 3% Growth ex-FX)